The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.

By G. Wormser, R. Dattwyler, Eugene D. Shapiro, John J. Halperin, Allen C. Steere, M. Klempner, P. Krause, J. S. Bakken, F. Strle, G. Stanek and 5 more. Clinical Infectious Diseases, 2006

1,978 citations recorded by the source corpus.

Subfields: Infectious Diseases, Parasitology

View Paper: https://www.semanticscholar.org/paper/c6e649149fa2559f8ac80ae25db20454eef9b331

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Å. Mygland
2. U. Ljøstad
3. E. Schmutzhard
4. S. O'connell
5. G. Stanek
6. J. Gray
7. I. Steiner
8. Volker Fingerle

Citations in the corpus

• Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. (2011, background): “Lyme borreliosis, caused by spirochaetes of the Borrelia burgdorferi genospecies complex, is the most commonly reported tick-borne infection in Europe and North America.”
• EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis (2010, methodology): “Data were collected by searching MEDLINE, EMBASE, the Cochrane databases and other evidencebased guidelines and reviews, including the practice parameters proposed by the American Academy of Neurology [8] and The Infectious Diseases Society of America guidelines [ 9 ].”